2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
48
Neoplasms
43
Depression
31
Fatigue
30
Prostatic Neoplasms
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Lymphoma, Follicular
18
Multiple Myeloma
16
Lymphoma, Large B-Cell, Diffuse
16
Carcinoma, Non-Small-Cell Lung
16
Lymphoma, Non-Hodgkin
15
Lung Neoplasms
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Mantle-Cell
14
Leukemia, Myeloid, Acute
14
Hodgkin Disease
14
Colorectal Neoplasms
14
Burkitt Lymphoma
14
Anxiety Disorders
14
Pain
13
Lymphoma, B-Cell, Marginal Zone
13
Lymphoma, Large-Cell, Immunoblastic
12
Lymphoma
11
Leukemia, Myeloid, Chronic-Phase
11
Head and Neck Neoplasms
11
Blast Crisis
11
Lymphoma, T-Cell, Cutaneous
10
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
10
Leukemia, Myeloid, Accelerated Phase
10
Leukemia, Hairy Cell
10
Interventions
Doxorubicin
17
Echocardiography
14
Exercise
9
Cyclophosphamide
9
Trastuzumab
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Therapeutics
×
Clear all
NCT02571894
2018-03-07
COBC
Karolinska University Hospital
Phase NA
Unknown
320 enrolled